Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity

Patrik Engström, Bidong D. Nguyen, Johan Normark, Ingela Nilsson, Robert J. Bastidas, Åsa Gylfe, Mikael Elofsson, Kenneth A. Fields, Raphael H. Valdivia, Hans Wolf-Watz, Sven Bergström

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Salicylidene acylhydrazides (SAHs) inhibit the type III secretion system (T3S) of Yersinia and other Gram-negative bacteria. In addition, SAHs restrict the growth and development of Chlamydia species. However, since the inhibition of Chlamydia growth by SAH is suppressed by the addition of excess iron and since SAHs have an iron-chelating capacity, their role as specific T3S inhibitors is unclear. We investigated here whether SAHs exhibit a function on C. trachomatis that goes beyond iron chelation. We found that the iron-saturated SAH INP0341 (IS-INP0341) specifically affects C. trachomatis infectivity with reduced generation of infectious elementary body (EB) progeny. Selection and isolation of spontaneous SAH-resistant mutant strains revealed that mutations in hemG suppressed the reduced infectivity caused by IS-INP0341 treatment. Structural modeling of C. trachomatis HemG predicts that the acquired mutations are located in the active site of the enzyme, suggesting that IS-INP0341 inhibits this domain of HemG and that protoporphyrinogen oxidase (HemG) and heme metabolism are important for C. trachomatis infectivity.

Original languageEnglish
Pages (from-to)4221-4230
Number of pages10
JournalJournal of Bacteriology
Volume195
Issue number18
DOIs
StatePublished - Sep 5 2013

Fingerprint

Protoporphyrinogen Oxidase
Chlamydia trachomatis
Iron
Mutation
Chlamydia
Yersinia
Gram-Negative Bacteria
Heme
Growth and Development
Catalytic Domain
Enzymes
Growth

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology

Cite this

Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity. / Engström, Patrik; Nguyen, Bidong D.; Normark, Johan; Nilsson, Ingela; Bastidas, Robert J.; Gylfe, Åsa; Elofsson, Mikael; Fields, Kenneth A.; Valdivia, Raphael H.; Wolf-Watz, Hans; Bergström, Sven.

In: Journal of Bacteriology, Vol. 195, No. 18, 05.09.2013, p. 4221-4230.

Research output: Contribution to journalArticle

Engström, P, Nguyen, BD, Normark, J, Nilsson, I, Bastidas, RJ, Gylfe, Å, Elofsson, M, Fields, KA, Valdivia, RH, Wolf-Watz, H & Bergström, S 2013, 'Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity', Journal of Bacteriology, vol. 195, no. 18, pp. 4221-4230. https://doi.org/10.1128/JB.00506-13
Engström, Patrik ; Nguyen, Bidong D. ; Normark, Johan ; Nilsson, Ingela ; Bastidas, Robert J. ; Gylfe, Åsa ; Elofsson, Mikael ; Fields, Kenneth A. ; Valdivia, Raphael H. ; Wolf-Watz, Hans ; Bergström, Sven. / Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity. In: Journal of Bacteriology. 2013 ; Vol. 195, No. 18. pp. 4221-4230.
@article{b4bb83c4d6b44ccdb32c8275b367aaa8,
title = "Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity",
abstract = "Salicylidene acylhydrazides (SAHs) inhibit the type III secretion system (T3S) of Yersinia and other Gram-negative bacteria. In addition, SAHs restrict the growth and development of Chlamydia species. However, since the inhibition of Chlamydia growth by SAH is suppressed by the addition of excess iron and since SAHs have an iron-chelating capacity, their role as specific T3S inhibitors is unclear. We investigated here whether SAHs exhibit a function on C. trachomatis that goes beyond iron chelation. We found that the iron-saturated SAH INP0341 (IS-INP0341) specifically affects C. trachomatis infectivity with reduced generation of infectious elementary body (EB) progeny. Selection and isolation of spontaneous SAH-resistant mutant strains revealed that mutations in hemG suppressed the reduced infectivity caused by IS-INP0341 treatment. Structural modeling of C. trachomatis HemG predicts that the acquired mutations are located in the active site of the enzyme, suggesting that IS-INP0341 inhibits this domain of HemG and that protoporphyrinogen oxidase (HemG) and heme metabolism are important for C. trachomatis infectivity.",
author = "Patrik Engstr{\"o}m and Nguyen, {Bidong D.} and Johan Normark and Ingela Nilsson and Bastidas, {Robert J.} and {\AA}sa Gylfe and Mikael Elofsson and Fields, {Kenneth A.} and Valdivia, {Raphael H.} and Hans Wolf-Watz and Sven Bergstr{\"o}m",
year = "2013",
month = "9",
day = "5",
doi = "10.1128/JB.00506-13",
language = "English",
volume = "195",
pages = "4221--4230",
journal = "Journal of Bacteriology",
issn = "0021-9193",
publisher = "American Society for Microbiology",
number = "18",

}

TY - JOUR

T1 - Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (hemG) and chlamydia trachomatis infectivity

AU - Engström, Patrik

AU - Nguyen, Bidong D.

AU - Normark, Johan

AU - Nilsson, Ingela

AU - Bastidas, Robert J.

AU - Gylfe, Åsa

AU - Elofsson, Mikael

AU - Fields, Kenneth A.

AU - Valdivia, Raphael H.

AU - Wolf-Watz, Hans

AU - Bergström, Sven

PY - 2013/9/5

Y1 - 2013/9/5

N2 - Salicylidene acylhydrazides (SAHs) inhibit the type III secretion system (T3S) of Yersinia and other Gram-negative bacteria. In addition, SAHs restrict the growth and development of Chlamydia species. However, since the inhibition of Chlamydia growth by SAH is suppressed by the addition of excess iron and since SAHs have an iron-chelating capacity, their role as specific T3S inhibitors is unclear. We investigated here whether SAHs exhibit a function on C. trachomatis that goes beyond iron chelation. We found that the iron-saturated SAH INP0341 (IS-INP0341) specifically affects C. trachomatis infectivity with reduced generation of infectious elementary body (EB) progeny. Selection and isolation of spontaneous SAH-resistant mutant strains revealed that mutations in hemG suppressed the reduced infectivity caused by IS-INP0341 treatment. Structural modeling of C. trachomatis HemG predicts that the acquired mutations are located in the active site of the enzyme, suggesting that IS-INP0341 inhibits this domain of HemG and that protoporphyrinogen oxidase (HemG) and heme metabolism are important for C. trachomatis infectivity.

AB - Salicylidene acylhydrazides (SAHs) inhibit the type III secretion system (T3S) of Yersinia and other Gram-negative bacteria. In addition, SAHs restrict the growth and development of Chlamydia species. However, since the inhibition of Chlamydia growth by SAH is suppressed by the addition of excess iron and since SAHs have an iron-chelating capacity, their role as specific T3S inhibitors is unclear. We investigated here whether SAHs exhibit a function on C. trachomatis that goes beyond iron chelation. We found that the iron-saturated SAH INP0341 (IS-INP0341) specifically affects C. trachomatis infectivity with reduced generation of infectious elementary body (EB) progeny. Selection and isolation of spontaneous SAH-resistant mutant strains revealed that mutations in hemG suppressed the reduced infectivity caused by IS-INP0341 treatment. Structural modeling of C. trachomatis HemG predicts that the acquired mutations are located in the active site of the enzyme, suggesting that IS-INP0341 inhibits this domain of HemG and that protoporphyrinogen oxidase (HemG) and heme metabolism are important for C. trachomatis infectivity.

UR - http://www.scopus.com/inward/record.url?scp=84883273494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883273494&partnerID=8YFLogxK

U2 - 10.1128/JB.00506-13

DO - 10.1128/JB.00506-13

M3 - Article

VL - 195

SP - 4221

EP - 4230

JO - Journal of Bacteriology

JF - Journal of Bacteriology

SN - 0021-9193

IS - 18

ER -